The Global Stem Cell/Chord Blood Banking Market Is Anticipated To Reach $11 Billion By 2022

The global stem cell/chord blood banking market was valued at about $7 billion in 2018 and is expected to grow to around $11 billion at a growth rate of around 12% through 2022.

Increasing number of cancer patients is a major driver for the stem cell /cord blood banking market. Cancer diseases such as leukemia and multiple myeloma can be treated by stem cell transplant. In stem cell transplant, treatment can be either done by autologous transplant in which the stem cells come from the same person who gets the transplant or by allogeneic transplant in which means the stem cells come from a matched related or unrelated donor. By using stem cells in the treatment of cancer, the blood forming stem cells which are damaged during chemotherapy can be restored.

Read More On The Global Stem Cell/Chord Blood Banking Market Report At

https://www.thebusinessresearchcompany.com/report/stem-cell-chord-blood-banking-global-market-report

The stem cell/cord blood banking global market consists of sales of stem cell/cord blood banking services and related goods. Cord stem cells are referred to as regenerative medicines which help in regeneration of tissues or cells in the body. Stem cells therapy is designed to aid the physician in performing medical treatment of different types of cancers, neurodegenerative diseases, graft-versus-host disease and heart diseases.

Important players in the global stem cell/chord blood banking market include AMAG Pharmaceuticals, Cordlife, Cryo-Cell International, Esperite, and Americord Registry LLC.

Request A Sample Of The Stem Cell/Chord Blood Banking Market Report At

https://www.thebusinessresearchcompany.com/sample.aspx?id=2514&type=smp

Pairing of cord blood and tissue storage with genetic testing services is an emerging trend in the stem cell/cord blood banking market. Such pairing is possible and efficient because of its complimentary services to the existing clients, thereby helping in expanding their product portfolio.

The healthcare services market, of which the stem cell/chord blood banking market is a segment, includes sales of healthcare services and related goods by entities (organizations, sole traders and partnerships) that provide human healthcare services. This industry includes establishments that provide services such as medical and diagnostic laboratory services, dental services, nursing care, residential substance abuse and mental health facilities and other healthcare services.

Read More On The Global Healthcare Services Market Report At

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

The stem cell/chord blood banking market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast growth by geography. It places the market within the context of the wider healthcare services market and compares it with other markets.

About The Business Research Company.

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Leave a Reply

Your email address will not be published. Required fields are marked *